Shopping Cart
- Remove All
Your shopping cart is currently empty
Fenoterol hydrobromide is an orally active and selective β2-adrenoceptor agonist and bronchodilator used in the study of cardiovascular diseases such as asthma and bronchitis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $29 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $74 | In Stock |
| Description | Fenoterol hydrobromide is an orally active and selective β2-adrenoceptor agonist and bronchodilator used in the study of cardiovascular diseases such as asthma and bronchitis. |
| In vitro | Fenoterol hydrobromide inhibited lipopolysaccharide (LPS)-induced AMPK activation and inflammatory cytokine production in THP-1 cells. Fenoterol hydrobromide treatment reduced AICAR-induced AMPK activation, NF-κB activation and TNF-α release, and also significantly down-regulated the elevated phosphorylation level of AMPK. [1] Fenoterol hydrobromide is a potent activator of exosome biogenesis and/or secretion in PC cells. [2] |
| In vivo | 0.7 mg/kg Fenoterol hydrobromide injected intraperitoneally twice daily was treated to suppress mechanically abnormal pain during chronic treatment. [3] |
| Molecular Weight | 384.27 |
| Formula | C17H22BrNO4 |
| Cas No. | 1944-12-3 |
| Smiles | Br.OC1=CC=C(C=C1)CC(NCC(O)C=2C=C(O)C=C(O)C2)C |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 20 mg/mL (52.05 mM), Sonication is recommended. DMSO: 80 mg/mL (208.19 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.